Ascendis Pharma A/S (ASND): Price and Financial Metrics
Ascendis Pharma A/S (ASND)
Today's Latest Price: $155.72 USD
Updated Jan 26 6:55pm
Add ASND to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ASND Stock Summary
- Ascendis Pharma A's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 9.35% of US listed stocks.
- With a price/sales ratio of 720.37, Ascendis Pharma A has a higher such ratio than 98.98% of stocks in our set.
- Revenue growth over the past 12 months for Ascendis Pharma A comes in at -56.01%, a number that bests merely 4.17% of the US stocks we're tracking.
- Stocks that are quantitatively similar to ASND, based on their financial statements, market capitalization, and price volatility, are KLDO, OTIC, PRTA, MRTX, and SNDX.
- Visit ASND's SEC page to see the company's official filings. To visit the company's web site, go to www.ascendispharma.com.
ASND Stock Price Chart Interactive Chart >
ASND Price/Volume Stats
| Current price | $155.72 | 52-week high | $183.98 |
| Prev. close | $158.89 | 52-week low | $92.00 |
| Day low | $153.72 | Volume | 329,300 |
| Day high | $161.00 | Avg. volume | 156,375 |
| 50-day MA | $166.77 | Dividend yield | N/A |
| 200-day MA | $151.10 | Market Cap | 8.32B |
Ascendis Pharma A/S (ASND) Company Bio
Ascendis Pharma A/S is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that address significant unmet medical needs. The company was founded in 2006 and is based in Hellerup, Denmark.
Loading social stream, please wait...